Cargando…
Patient acceptability of targeted risk-based detection of non-communicable diseases in a dental and pharmacy setting
BACKGROUND: Non-communicable diseases [NCDs] are the major cause of mortality globally and are increasing in prevalence. Different healthcare professionals’ access different population groups; and engaging allied healthcare professionals in risk-driven early case detection of certain NCDs may be ben...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7576866/ https://www.ncbi.nlm.nih.gov/pubmed/33081745 http://dx.doi.org/10.1186/s12889-020-09649-7 |
_version_ | 1783598101649424384 |
---|---|
author | Yonel, Zehra Yahyouche, Asma Jalal, Zahra James, Alistair Dietrich, Thomas Chapple, Iain L. C. |
author_facet | Yonel, Zehra Yahyouche, Asma Jalal, Zahra James, Alistair Dietrich, Thomas Chapple, Iain L. C. |
author_sort | Yonel, Zehra |
collection | PubMed |
description | BACKGROUND: Non-communicable diseases [NCDs] are the major cause of mortality globally and are increasing in prevalence. Different healthcare professionals’ access different population groups; and engaging allied healthcare professionals in risk-driven early case detection of certain NCDs may be beneficial, especially those who have not been tested for NCDs within the previous 12 months. The objectives of this study were to determine: whether NCD case finding in dental/community pharmacy settings is feasible in terms of patient acceptability, barriers to recruitment, impact on the existing service. Determine time taken to test for: type 2 diabetes risk [T2DM], chronic obstructive pulmonary disease [COPD], hypertension, vitamin D deficiency and chronic kidney disease [CKD]. Determine whether there is added benefit of point of care testing [POCT] to identify diabetes risk compared to a validated screening questionnaire alone. METHODS: An exploratory study was undertaken to explore issues associated with NCD assessment in one dental practice and one community pharmacy within the West-Midlands, UK. Fifty patients > 40 years-of-age were recruited per site. Participants undertook: a questionnaire providing demographic data, any previous NCD diagnosis or positive family history. Validated questionnaires for determining NCD risk [T2DM/COPD]. Chair-side capillary blood [finger-prick] samples for HbA1C, creatinine/eGFR, Vitamin-D. Prior work had been undertaken to measure the agreement between point of care testing [POCT] devices and a central laboratory method, and to gauge the opinions of participants regarding discomfort experienced using venous (antecubital fossa) and capillary (finger-prick) blood collection, via a 10 cm Visual-Analogue-Scale. The POCT devices demonstrated good concordance with laboratory testing and were acceptable methods of blood collection for participants. RESULTS: Recruitment rates demonstrated that 8 days were needed to recruit 50 participants and 60% of those approached opted to participate. The principal barrier to participation was time, with average time taken to test being 19mins. Utilising dental and pharmacy settings identified potential cases of previously undiagnosed disease. CONCLUSIONS: Risk-targeted testing for NCDs in high street dental and community pharmacies is both attractive and acceptable to patients. |
format | Online Article Text |
id | pubmed-7576866 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-75768662020-10-22 Patient acceptability of targeted risk-based detection of non-communicable diseases in a dental and pharmacy setting Yonel, Zehra Yahyouche, Asma Jalal, Zahra James, Alistair Dietrich, Thomas Chapple, Iain L. C. BMC Public Health Research Article BACKGROUND: Non-communicable diseases [NCDs] are the major cause of mortality globally and are increasing in prevalence. Different healthcare professionals’ access different population groups; and engaging allied healthcare professionals in risk-driven early case detection of certain NCDs may be beneficial, especially those who have not been tested for NCDs within the previous 12 months. The objectives of this study were to determine: whether NCD case finding in dental/community pharmacy settings is feasible in terms of patient acceptability, barriers to recruitment, impact on the existing service. Determine time taken to test for: type 2 diabetes risk [T2DM], chronic obstructive pulmonary disease [COPD], hypertension, vitamin D deficiency and chronic kidney disease [CKD]. Determine whether there is added benefit of point of care testing [POCT] to identify diabetes risk compared to a validated screening questionnaire alone. METHODS: An exploratory study was undertaken to explore issues associated with NCD assessment in one dental practice and one community pharmacy within the West-Midlands, UK. Fifty patients > 40 years-of-age were recruited per site. Participants undertook: a questionnaire providing demographic data, any previous NCD diagnosis or positive family history. Validated questionnaires for determining NCD risk [T2DM/COPD]. Chair-side capillary blood [finger-prick] samples for HbA1C, creatinine/eGFR, Vitamin-D. Prior work had been undertaken to measure the agreement between point of care testing [POCT] devices and a central laboratory method, and to gauge the opinions of participants regarding discomfort experienced using venous (antecubital fossa) and capillary (finger-prick) blood collection, via a 10 cm Visual-Analogue-Scale. The POCT devices demonstrated good concordance with laboratory testing and were acceptable methods of blood collection for participants. RESULTS: Recruitment rates demonstrated that 8 days were needed to recruit 50 participants and 60% of those approached opted to participate. The principal barrier to participation was time, with average time taken to test being 19mins. Utilising dental and pharmacy settings identified potential cases of previously undiagnosed disease. CONCLUSIONS: Risk-targeted testing for NCDs in high street dental and community pharmacies is both attractive and acceptable to patients. BioMed Central 2020-10-20 /pmc/articles/PMC7576866/ /pubmed/33081745 http://dx.doi.org/10.1186/s12889-020-09649-7 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Article Yonel, Zehra Yahyouche, Asma Jalal, Zahra James, Alistair Dietrich, Thomas Chapple, Iain L. C. Patient acceptability of targeted risk-based detection of non-communicable diseases in a dental and pharmacy setting |
title | Patient acceptability of targeted risk-based detection of non-communicable diseases in a dental and pharmacy setting |
title_full | Patient acceptability of targeted risk-based detection of non-communicable diseases in a dental and pharmacy setting |
title_fullStr | Patient acceptability of targeted risk-based detection of non-communicable diseases in a dental and pharmacy setting |
title_full_unstemmed | Patient acceptability of targeted risk-based detection of non-communicable diseases in a dental and pharmacy setting |
title_short | Patient acceptability of targeted risk-based detection of non-communicable diseases in a dental and pharmacy setting |
title_sort | patient acceptability of targeted risk-based detection of non-communicable diseases in a dental and pharmacy setting |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7576866/ https://www.ncbi.nlm.nih.gov/pubmed/33081745 http://dx.doi.org/10.1186/s12889-020-09649-7 |
work_keys_str_mv | AT yonelzehra patientacceptabilityoftargetedriskbaseddetectionofnoncommunicablediseasesinadentalandpharmacysetting AT yahyoucheasma patientacceptabilityoftargetedriskbaseddetectionofnoncommunicablediseasesinadentalandpharmacysetting AT jalalzahra patientacceptabilityoftargetedriskbaseddetectionofnoncommunicablediseasesinadentalandpharmacysetting AT jamesalistair patientacceptabilityoftargetedriskbaseddetectionofnoncommunicablediseasesinadentalandpharmacysetting AT dietrichthomas patientacceptabilityoftargetedriskbaseddetectionofnoncommunicablediseasesinadentalandpharmacysetting AT chappleiainlc patientacceptabilityoftargetedriskbaseddetectionofnoncommunicablediseasesinadentalandpharmacysetting |